# Open Questions

Items that need further clarification or decisions before the committee proposal can be finalised.

## Committee Structure

- [ ] What is the formal name? (Medical Advisory Committee / Clinical Governance Advisory Board / other)
- [ ] Who will chair the committee?
- [ ] What are the terms of reference (meeting frequency, quorum, decision-making process)?
- [ ] Will members be compensated or serve in an advisory capacity pro bono?
- [ ] What is the term length for membership?
- [ ] How does the committee formally submit proposals to the corporate board?

## Membership

- [ ] What are Aida Yousefi's and Mohammed Desai's professional backgrounds and qualifications?
- [ ] Are all proposed members external advisors, or are some internal Sanctura staff?
- [ ] Is five members the intended final size, or are additional members anticipated?
- [ ] What roles do Carrie and Ismael play â€” are they potential members or subject-matter contacts?

## Scope & Priorities

- [ ] Which agenda items should the committee tackle first?
- [ ] Is the GMC doctor recruitment something the MAC should formally oversee?
- [ ] What level of decision-making authority does the MAC have vs. purely advisory?
- [ ] Should international expansion items (Portugal, UAE) be in scope for the UK MAC, or deferred to a separate process?

## Operational

- [ ] Where will the committee meet (Sanctura UK clinic, virtual, hybrid)?
- [ ] Who handles committee administration (minutes, scheduling, follow-ups)?
- [ ] Are there existing governance documents or templates from the corporate board to build on?
- [ ] What is the target date for the first formal committee meeting?
